Covid rebound hits 1 in 5 Paxlovid-treated people in small study

Pfizer Inc.'s Paxlovid was linked to a high rate of Covid rebound in a small study that suggests people taking the pill, along with their families and close contacts, should

Related Keywords

Massachusetts ,United States ,Boston ,Mark Siedner ,Pfizer Inc ,Pfizer ,Internal Medicine ,Massachusetts General Hospital ,Covid Rebound ,Paxlovid ,